Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Cardiovascular Endocrinology

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1650319

This article is part of the Research TopicMetabolic Pathways to Multiple Long-term Conditions (Multimorbidity): Focusing on Cardio-metabolic Multimorbidity (CMM)View all 12 articles

Association of pan-immune-inflammation value and atherogenic index of plasma with chronic coronary syndrome in non-alcoholic fatty liver disease patients

Provisionally accepted
Bing  YuBing Yu1*Jianqi  ZhaoJianqi Zhao2Wenjing  ZhangWenjing Zhang1Leigang  WangLeigang Wang1Xin  ZhenXin Zhen1Xin  LiXin Li1Zhong  YaoZhong Yao1Yao  SunYao Sun1Zhaoyu  RenZhaoyu Ren1Bin  LiangBin Liang1*
  • 1Second Hospital of Shanxi Medical University Department of Cardiology, Taiyuan, China
  • 2The First People's Hospital of Jinzhong, Jinzhong, China

The final, formatted version of the article will be published soon.

Non-alcoholic fatty liver disease (NAFLD) is linked to a higher risk of cardiovascular disease, particularly chronic coronary syndrome (CCS). However, reliable biomarkers for early CCS risk stratification in NAFLD patients remain lacking. This study aims to assess the pan-immuneinflammation value (PIV) and atherogenic index of plasma (AIP) for CCS in NAFLD patients and to construct a practical tool for personalized risk assessment.This retrospective study included 459 NAFLD patients undergoing coronary angiography. Least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression were used to discover independent risk variables for CCS. A nomogram was constructed to quantify CCS risk. Model performance was evaluated by calibration curves, concordance index, and decision curve analysis (DCA). Trend tests assessed the relationship between PIV, AIP quartiles, and CCS risk, while quantile regression analyzed their associations with coronary lesion severity (Gensini scores).Eight independent variables were identified. Elevated lnPIV (OR, 2.195; 95% CI, 1.564-3.125; P < 0.001) and AIP (OR, 4.147; 95% CI, 1.770-10.095; P < 0.001) were strongly associated with CCS. The nomogram demonstrated good discrimination (C-index = 0.782) and calibration. Trend tests revealed a significant positive correlation between lnPIV/AIP quartiles and CCS risk (P for trend < 0.05). Quantile regression further indicated that lnPIV and AIP positively correlated with higher Gensini scores.

Keywords: Non-alcoholic fatty liver disease, Chronic coronary syndrome, nomogram, Atherogenic index of plasma, Pan-Immune-Inflammation Value

Received: 19 Jun 2025; Accepted: 15 Aug 2025.

Copyright: © 2025 Yu, Zhao, Zhang, Wang, Zhen, Li, Yao, Sun, Ren and Liang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Bing Yu, Second Hospital of Shanxi Medical University Department of Cardiology, Taiyuan, China
Bin Liang, Second Hospital of Shanxi Medical University Department of Cardiology, Taiyuan, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.